In contrast, increased number of BM nestin+ cells have been reported in AML mice transplanted with serially passaged hematopoietic cells transformed with a retrovirally expressed MLL-AF9 fusion oncogene (Hanoun et al., 2014). The gene discussed is KMT2A; the disease is acute myeloid leukemia.